226 related articles for article (PubMed ID: 28489605)
1. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.
Iżykowska K; Przybylski GK; Gand C; Braun FC; Grabarczyk P; Kuss AW; Olek-Hrab K; Bastidas Torres AN; Vermeer MH; Zoutman WH; Tensen CP; Schmidt CA
Oncotarget; 2017 Jun; 8(24):39627-39639. PubMed ID: 28489605
[TBL] [Abstract][Full Text] [Related]
2. Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome.
Iżykowska K; Zawada M; Nowicka K; Grabarczyk P; Braun FCM; Delin M; Möbs M; Beyer M; Sterry W; Schmidt CA; Przybylski GK
J Invest Dermatol; 2013 Nov; 133(11):2617-2625. PubMed ID: 23698072
[TBL] [Abstract][Full Text] [Related]
3. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
4. Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome.
Prasad A; Rabionet R; Espinet B; Zapata L; Puiggros A; Melero C; Puig A; Sarria-Trujillo Y; Ossowski S; Garcia-Muret MP; Estrach T; Servitje O; Lopez-Lerma I; Gallardo F; Pujol RM; Estivill X
J Invest Dermatol; 2016 Jul; 136(7):1490-1499. PubMed ID: 27039262
[TBL] [Abstract][Full Text] [Related]
5. Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.
Caprini E; Bresin A; Cristofoletti C; Helmer Citterich M; Tocco V; Scala E; Monopoli A; Benucci R; Narducci MG; Russo G
Cell Death Dis; 2018 Dec; 9(12):1178. PubMed ID: 30518749
[TBL] [Abstract][Full Text] [Related]
6. Sézary syndrome: old enigmas, new targets.
Nicolay JP; Felcht M; Schledzewski K; Goerdt S; Géraud C
J Dtsch Dermatol Ges; 2016 Mar; 14(3):256-64. PubMed ID: 26972187
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts.
Lee CS; Ungewickell A; Bhaduri A; Qu K; Webster DE; Armstrong R; Weng WK; Aros CJ; Mah A; Chen RO; Lin M; Sundram U; Chang HY; Kretz M; Kim YH; Khavari PA
Blood; 2012 Oct; 120(16):3288-97. PubMed ID: 22936659
[TBL] [Abstract][Full Text] [Related]
9. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2001 Sep; 117(3):663-70. PubMed ID: 11564174
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells.
Iżykowska K; Rassek K; Żurawek M; Nowicka K; Paczkowska J; Ziółkowska-Suchanek I; Podralska M; Dzikiewicz-Krawczyk A; Joks M; Olek-Hrab K; Giefing M; Przybylski GK
J Cell Mol Med; 2020 Sep; 24(18):10970-10977. PubMed ID: 32794659
[TBL] [Abstract][Full Text] [Related]
11. Novel and highly recurrent chromosomal alterations in Sézary syndrome.
Vermeer MH; van Doorn R; Dijkman R; Mao X; Whittaker S; van Voorst Vader PC; Gerritsen MJ; Geerts ML; Gellrich S; Söderberg O; Leuchowius KJ; Landegren U; Out-Luiting JJ; Knijnenburg J; Ijszenga M; Szuhai K; Willemze R; Tensen CP
Cancer Res; 2008 Apr; 68(8):2689-98. PubMed ID: 18413736
[TBL] [Abstract][Full Text] [Related]
12. Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.
Persson M; Andrén Y; Moskaluk CA; Frierson HF; Cooke SL; Futreal PA; Kling T; Nelander S; Nordkvist A; Persson F; Stenman G
Genes Chromosomes Cancer; 2012 Aug; 51(8):805-17. PubMed ID: 22505352
[TBL] [Abstract][Full Text] [Related]
13. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.
Wang L; Ni X; Covington KR; Yang BY; Shiu J; Zhang X; Xi L; Meng Q; Langridge T; Drummond J; Donehower LA; Doddapaneni H; Muzny DM; Gibbs RA; Wheeler DA; Duvic M
Nat Genet; 2015 Dec; 47(12):1426-34. PubMed ID: 26551670
[TBL] [Abstract][Full Text] [Related]
14. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome.
Limon J; Nedoszytko B; Brozek I; Hellmann A; Zajaczek S; Lubiński J; Mrózek K
Cancer Genet Cytogenet; 1995 Aug; 83(1):75-81. PubMed ID: 7656210
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription.
Wang Y; Su M; Zhou LL; Tu P; Zhang X; Jiang X; Zhou Y
Blood; 2011 Apr; 117(14):3826-35. PubMed ID: 21270445
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic tools in Sezary syndrome.
Möbs M; Knott M; Fritzen B; Pullmann S; Sterry W; Assaf C
G Ital Dermatol Venereol; 2010 Jun; 145(3):385-91. PubMed ID: 20461046
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.
Weng WK; Armstrong R; Arai S; Desmarais C; Hoppe R; Kim YH
Sci Transl Med; 2013 Dec; 5(214):214ra171. PubMed ID: 24307695
[TBL] [Abstract][Full Text] [Related]
18. Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.
Butler RM; McKenzie RC; Jones CL; Flanagan CE; Woollard WJ; Demontis M; Ferreira S; Tosi I; John S; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2019 Sep; 139(9):1975-1984.e2. PubMed ID: 30910759
[TBL] [Abstract][Full Text] [Related]
19. TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma.
Gros A; Laharanne E; Vergier M; Prochazkova-Carlotti M; Pham-Ledard A; Bandres T; Poglio S; Berhouet S; Vergier B; Vial JP; Chevret E; Beylot-Barry M; Merlio JP
PLoS One; 2017; 12(3):e0173171. PubMed ID: 28301507
[TBL] [Abstract][Full Text] [Related]
20. Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine.
Chevret E; Merlio JP
J Invest Dermatol; 2016 Jul; 136(7):1319-1324. PubMed ID: 27342034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
